Evaluation of tuberculosis infection in COVID-19 patients: a case of tuberculosis and COVID-19 co-infection
Hamid Reza Niazkar, Behdad Zibaee, Behzad Razavi, Kasra Ghanaeian, Vahid Talebzadeh, Negin Haji Vosugh
The Egyptian Journal of Internal Medicine · 2022-06
Abstract
The COVID-19 pandemic affected millions of people worldwide, becoming a challenge of every nation. Since the COVID-19 can present wide spectrum of clinical signs and symptoms, patients with symptoms similar to that of COVID-19 may be misdiagnosed during the context of COVID-19 pandemic. In this regard, various co-infections may affect the outcome of COVID-19 patients if it lefts undiagnosed, especially during the administration of immunosuppressive drugs. Similar to COVID-19, TB affect the lungs and respiratory airways primarily. These two diseases have resembling symptoms, including dry cough, fever, and dyspnea. Due to the importance of early COVID-19 diagnosis, many other respiratory infectious diseases such as tuberculosis (TB) may be missed. Herein, a case of COVID-19 and tuberculosis co-infection is presented.
MeSH terms
- Medicine
- Tuberculosis
- Pandemic
- Coronavirus disease 2019 (COVID-19)
- Context (archaeology)
- Intensive care medicine
- Pneumonia
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Immunology
- Infectious disease (medical specialty)